Comment · Tue, March 17, 2015 · Ceretropic
Ceretropic Stocks Tianeptine Sulphate
Original post in this thread
relbatnrut · 56 points
"There are a few problems with the common form of Tianeptine, the sodium salt. For one, it is very hygroscopic. This makes handling and storage a pain. More importantly, its short half life and pharmacodynamic properties make dosing required up to 3 times a day. This is where a more controlled release form comes into play.
Tianeptine hemisulfate monohydrate is an improved salt of Tianeptine. It is not hygroscopic, so handling the powder is a lot easier. Since it is not as readily absorbed and excreted from the body, the sulfate salt allows for a more controlled release of the Tianeptine over longer periods. Rather than having to dose three times, with rapid peak effects and rapidly falling effects, the sulfate salt allows for one dose to maintain plasma levels in the body much longer than the sodium salt. These improved characteristics make Tianeptine Sulfate a novel addition."
What they were answering
Bukujutsu · 1 points
patent risks
Would it be a good idea to change the product description and URL so that a search engine doesn't lead them right to the page? May be better to replace it with something that can't be indexed.
Right now when I do a non-personalized strict search for both terms Ceretropic shows up right on the first and second pages.
u/MisterYouAreSoDumb · Ceretropic
It's a balance. I need to give people the exact information of the compound they are buying, and have it so that people that hear about it can find us. I doubt the patent holder is Googling the name all the time to see what is going on. But we are the first people to ever do this compound. It does not even have a CAS yet. So all roads are going to point to us, no matter what I change the description and wording to. We'll see if the patent holder cares about us or not.